Following the government’s guidelines to reduce paper consumption, the Federal Drug Administration began, on December 3, 2021, issuing electronic CPP’s (Certificates of Pharmaceutical Product).
The European Union and Canada and several other countries have already implemented electronic pharmaceutical certificates, using secure electronic signatures, as requested by the World Health Organization.
A critical document in the export of pharmaceutical products to overseas markets, the new eCPP will continue to require apostille and legalization, depending on the countries to which they are being exported.
WCS, who had previously worked closely with the U.S. State Department to resume normal turnaround times for document processing, is now verifying the workflows, yet undefined, that will allow for timely processing of the FDA’s new e-documents.
On behalf of our pharmaceutical customers, we will print out the e-certificates and deliver them to the State Department for processing, as per the usual practice.
Whenever the State Department authorizes electronic processing, we are prepared to cut-over to a paper-free processing environment.
Stay tuned for further developments and contact us with any questions.